ProMIS Neurosciences, Inc. Stock Toronto S.E.
Equities
PMN
CA74346M4065
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 49.56M 36.2M |
---|---|---|---|---|---|
Net income 2024 * | -38M -27.75M | Net income 2025 * | -46M -33.59M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.78
x | P/E ratio 2025 * |
-1.79
x | Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.65% |
Managers | Title | Age | Since |
---|---|---|---|
Neil Warma
CEO | Chief Executive Officer | 61 | 21-05-12 |
Neil Cashman
FOU | Founder | 72 | 04-01-22 |
Eugene Williams
CHM | Chairman | 64 | 15-06-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
William W. Wyman
BRD | Director/Board Member | 86 | 14-03-07 |
Neil Cashman
FOU | Founder | 72 | 04-01-22 |
Neil Warma
CEO | Chief Executive Officer | 61 | 21-05-12 |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.86% | 22.2B | |
-16.53% | 21.23B | |
-8.49% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |